Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract
Authors:
- Alexander VogetsederAVAlexander Vogetseder
- Bernhard C. PestalozziBPBernhard C. Pestalozzi
- Pierre-Alain ClavienPCPierre-Alain Clavien
- Nicole Probst-HenschNPNicole Probst-Hensch
- Glen KristiansenGKGlen Kristiansen
- Wolfram JochumWJWolfram Jochum
- 1 November 2010
- journal article
- Published by Elsevier in Human Pathology
- Vol. 41 (11) , 1558-1565
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- CD24 Expression is an Independent Prognostic Marker in CholangiocarcinomaJournal of Gastrointestinal Surgery, 2007
- S-100A4 Protein and Mesothelin Expression in Dysplasia and Carcinoma of the Extrahepatic Bile DuctAmerican Journal of Clinical Pathology, 2007
- Advanced Cytologic Techniques for the Detection of Malignant Pancreatobiliary StricturesGastroenterology, 2006
- Telomere length variation in biliary tract metaplasia, dysplasia, and carcinomaLaboratory Investigation, 2006
- CholangiocarcinomaThe Lancet, 2005
- Cytoplasmic CD24 Expression in Colorectal Cancer Independently Correlates with Shortened Patient SurvivalClinical Cancer Research, 2005
- P-Cadherin Overexpression Is an Indicator of Clinical Outcome in Invasive Breast Carcinomas and Is Associated with CDH3 Promoter HypomethylationClinical Cancer Research, 2005
- Immunohistochemical study of characteristics of bile duct dysplasia evaluated on the basis of expression of metastasis/invasion-related factors and p53Journal of Hepato-Biliary-Pancreatic Surgery, 2004
- CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancerThe Prostate, 2003
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998